ArticleCancer chemotherapy and pharmacology2021

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.